Viewing Study NCT05220033

Home

Certify Doc

Genes

Clinical Trials

CompTox

DrugMatrix

Open Targets

Products

Support

Bugs

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-25 @ 2:51 AM

Ignite Modification Date: 2025-12-30 @ 12:41 PM

Study NCT ID: NCT05220033

Status: ACTIVE_NOT_RECRUITING

Last Update Posted: 2025-03-18

First Post: 2021-11-22

Is NOT Gene Therapy: True

Has Adverse Events: False

Brief Title: Journey Ahead: Enhancing Coping and Communication for Women Diagnosed With Gynecological Cancer

Sponsor: Rutgers, The State University of New Jersey

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Overview

Official Title: Journey Ahead: Enhancing Coping and Communication for Women Diagnosed With Gynecological Cancer

Status: ACTIVE_NOT_RECRUITING

Status Verified Date: 2025-03

Last Known Status: None

Delayed Posting: No

If Stopped, Why?: Not Stopped

Has Expanded Access: False

If Expanded Access, NCT#: N/A

Has Expanded Access, NCT# Status: N/A

Acronym: None

Brief Summary: This study looks at how well the Journey Ahead intervention works in improving coping and communication skills in participants with gynecologic cancers.

Detailed Description: Primary goals of this project are:

Objective 1: Phase 1: To collect feedback from patients on CCI online and to assess patient's evaluation of CCI online.

Objective 2: Phase 1: To examine the feasibility and acceptability of a CCI online.

Objective 3: Phase 1/2: To collect preliminary data on changes in distress and coping associated with participation in CCI online.

Study Oversight

Has Oversight DMC: True

Is a FDA Regulated Drug?: False

Is a FDA Regulated Device?: False

Is an Unapproved Device?: None

Is a PPSD?: None

Is a US Export?: None

Is an FDA AA801 Violation?:

Secondary ID Infos

Secondary ID	Type	Domain	Link	View

131908	OTHER	Rutgers, The State University of New Jersey		View